Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism Pharmaceutical Investing
Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder Life Science Investing
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile Psychedelics Investing
Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa SmartNews
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection Life Science Investing
AbbVie Announces TEPKINLY® in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma Pharmaceutical Investing
A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs Life Science Investing
